FZD4-DT: A Drug Target / Disease Biomarker (G100506368)

Target Name: FZD4-DT

NCBI ID: G100506368

FZD4-DT

Other Name(s): FZD4 divergent transcript

FZD4-DT: A Drug Target / Disease Biomarker

FZD4-DT is a protein that is expressed in the brain and is known for its role in the development and progression of several neurological disorders, including Alzheimer's disease. The protein is a potential drug target (or biomarker) for the treatment of these disorders.

FZD4-DT is a transmembrane protein that is expressed in the brain and is involved in the regulation of several cellular processes, including the transport of nutrients, oxygen, and waste products into the brain. It is a key regulator of the blood-brain barrier, which is a barrier that separates the brain from the surrounding blood vessels and is designed to protect the brain from harmful substances.

Mutations in the FZD4-DT gene have been linked to the development of several neurological disorders, including Alzheimer's disease. These mutations have been shown to disrupt the function of FZD4-DT and to contribute to the progression of these disorders.

In addition to its role in the development and progression of neurological disorders, FZD4-DT has also been shown to play a key role in the regulation of the brain-body interface. This interface is the communication system between the brain and the rest of the body, and it allows the brain to control the body's movements and other functions.

FZD4-DT has been shown to play a key role in the regulation of movement and emotion. Studies have shown that FZD4-DT is involved in the regulation of muscle tone and that it is involved in the development of emotional responses.

FZD4-DT has also been shown to play a key role in the regulation of the immune system. This system is responsible for protecting the body against harmful substances, and it is thought to be involved in the development of autoimmune disorders.

In addition to its role in the regulation of the immune system, FZD4-DT has also been shown to play a key role in the regulation of the blood-brain barrier. This barrier is responsible for protecting the brain from harmful substances, and it is thought to be involved in the development of several neurological disorders, including Alzheimer's disease.

FZD4-DT has been shown to be involved in the regulation of several cellular processes that are important for the development and progression of neurological disorders. For example, studies have shown that FZD4-DT is involved in the regulation of the transport of nutrients, oxygen, and waste products into the brain, and that it is involved in the regulation of the immune system.

In conclusion, FZD4-DT is a protein that is expressed in the brain and is involved in several cellular processes that are important for the development and progression of neurological disorders. The protein is a potential drug target (or biomarker) for the treatment of these disorders and may be a useful tool in the development of new treatments for these conditions.

Protein Name: FZD4 Divergent Transcript

The "FZD4-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FZD4-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets